Literature DB >> 26788203

Expression of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma and its clinical significance.

Liansheng Qiu1, Jiabao Lv2, Yimin Chen1, Jiarong Wang1, Ruishan Wu1.   

Abstract

The aim of the present study was to determine the effect of S-phase kinase-associated protein 2 (Skp2) and cyclin-dependent kinase inhibitor p27kinase-interacting protein 1 (p27kip1) protein expression on the occurrence and development of hypopharyngeal squamous cell carcinoma. The protein expression levels of Skp2 and p27kip1 were detected in 42 hypopharyngeal squamous cell carcinoma and 15 normal hypopharyngeal mucous membrane specimens using the an immunohistochemical PV-9000 two-step method. The expression levels of Skp2 protein were significantly different in hypopharyngeal squamous cell carcinomas and normal hypopharyngeal mucous membranes (61.90 vs. 26.67%; P<0.05). By contrast, the protein expression levels of Skp2 were significantly positively correlated with tumor T stage (rs=0.329, P<0.05) and cervical lymph node metastasis (rs=0.402, P<0.05). Furthermore, the expression levels of p27kip1 protein were significantly different in hypopharyngeal squamous cell carcinomas and normal hypopharyngeal mucous membranes (11.9 vs. 53.33%; P<0.05), while p27kip1 protein expression was significantly negatively correlated with tumor T-stage (rs=-0.351, P<0.05) and cervical lymph node metastasis (rs=-0.371, P<0.05). Notably, a significant negative correlation was observed between the expression levels of Skp2 and p27kip1 proteins in hypopharyngeal squamous cell carcinoma (P<0.05). In addition, abnormal expression levels of Skp2 and p27kip1 proteins were observed in hypopharyngeal squamous cell carcinoma tissues. Thus, Skp2 and p27kip1 proteins may be involved in the development of hypopharyngeal squamous cell carcinoma. The current study proposed that combined detection of Skp2 and p27kip1 may be useful for assessing the characteristics and prognosis of hypopharyngeal squamous cell carcinoma.

Entities:  

Keywords:  S-phase kinase-associated protein 2; cancer; cyclin-dependent kinase inhibitor p27kinase-interacting protein 1; hypopharyngeal carcinoma; immunohistochemistry; squamous cell

Year:  2015        PMID: 26788203      PMCID: PMC4665224          DOI: 10.3892/ol.2015.3799

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  22 in total

1.  Acetylation-dependent regulation of Skp2 function.

Authors:  Hiroyuki Inuzuka; Daming Gao; Lydia W S Finley; Wen Yang; Lixin Wan; Hidefumi Fukushima; Y Rebecca Chin; Bo Zhai; Shavali Shaik; Alan W Lau; Zhiwei Wang; Steven P Gygi; Keiko Nakayama; Julie Teruya-Feldstein; Alex Toker; Marcia C Haigis; Pier Paolo Pandolfi; Wenyi Wei
Journal:  Cell       Date:  2012-07-06       Impact factor: 41.582

2.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.

Authors:  A C Carrano; E Eytan; A Hershko; M Pagano
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

3.  Skp2 is required for incretin hormone-mediated β-cell proliferation.

Authors:  Shuen-Ing Tschen; Senta Georgia; Sangeeta Dhawan; Anil Bhushan
Journal:  Mol Endocrinol       Date:  2011-10-06

4.  Skp2 is oncogenic and overexpressed in human cancers.

Authors:  M Gstaiger; R Jordan; M Lim; C Catzavelos; J Mestan; J Slingerland; W Krek
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

5.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.

Authors:  K Nakayama; H Nagahama; Y A Minamishima; M Matsumoto; I Nakamichi; K Kitagawa; M Shirane; R Tsunematsu; T Tsukiyama; N Ishida; M Kitagawa; K Nakayama; S Hatakeyama
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

6.  Overexpression of Skp2 in carcinoma of the cervix does not correlate inversely with p27 expression.

Authors:  S E Dowen; A Scott; G Mukherjee; M A Stanley
Journal:  Int J Cancer       Date:  2003-06-20       Impact factor: 7.396

Review 7.  Regulation of the cdk inhibitor p27 and its deregulation in cancer.

Authors:  J Slingerland; M Pagano
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

Review 8.  TNM staging of cancers of the head and neck: striving for uniformity among diversity.

Authors:  Snehal G Patel; Jatin P Shah
Journal:  CA Cancer J Clin       Date:  2005 Jul-Aug       Impact factor: 508.702

9.  High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.

Authors:  Y Kudo; S Kitajima; S Sato; M Miyauchi; I Ogawa; T Takata
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

10.  p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase.

Authors:  H Zhang; R Kobayashi; K Galaktionov; D Beach
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

View more
  1 in total

Review 1.  APC/C and retinoblastoma interaction: cross-talk of retinoblastoma protein with the ubiquitin proteasome pathway.

Authors:  Ajeena Ramanujan; Swati Tiwari
Journal:  Biosci Rep       Date:  2016-09-16       Impact factor: 3.840

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.